Following acute occlusion of a coronary artery causing myocardial ischemia and
implementing first-line treatment involving rapid reperfusion, a dynamic and balanced …

Acute myocardial infarction can be treated aggressively with intravenous thrombolysis,
percutaneous coronary intervention, and coronary artery bypass grafting; however …

In the past 2 decades, research on atherosclerotic cardiovascular disease has uncovered
inflammation to be a key driver of the pathophysiological process. A pressing need therefore …

To reduce the mortality of myocardial infarction (MI), accurate detection of the infarct and
appropriate prevention against ischemia/reperfusion (I/R) induced cardiac dysfunction are …

Background and aims The scientific community is concerned about cardiovascular disease
mortality and morbidity, especially myocardial infarction (MI). Schisantherin A (SCA), a …

In the present study, we assessed the therapeutic potential of Biochanin-A (BCA)(10 mg/kg
BW/day) pretreatment for 30 days on lipid metabolic abnormalities, proinflammatory …

Swimming is important for promoting and maintaining health, as it can increase the
efficiency of the cardiovascular system and decrease the occurrence of cardiovascular …

Myocardial infarction (MI) remains the leading cause of death in the western world. Despite
advancements in interventional revascularization technologies, many patients are not …

Novel therapeutic strategies aiming at improving the healing process after an acute
myocardial infarction are currently under intense investigation. The mouse model plays a …

Background The serum levels of sclerostin (SOST) are significant elevated in patients with
pathological cardiac remodeling after myocardial infarction (MI). However, the mechanisms …